article thumbnail

Cell and Gene Therapy Bioassay – A Prerequisite for the ATMPs Development

Roots Analysis

Bioassay – A Prerequisite for the Cell and Gene Therapy Development. Over the past few years, investigational new drug (IND) filings for cell and gene therapy product have significantly increased. Bioassays are biochemical procedures that are used to evaluate the potency, purity and efficacy of a drug substance.

article thumbnail

KBI Biopharma Completes Eurofins DiscoverX Products Specialized Bioassay Certification Program

BioTech 365

& … Continue reading →

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Toregem BioPharma and WuXi Biologics to partner for antibody development

Pharmaceutical Technology

As part of the collaboration, Toregem will use WuXi Biologics’ integrated CMC services in cell culture development, cell line development, bioassay development, biologics GMP manufacturing, cell banking and testing services, as well as other related services. TRG035’s Phase I clinical study is scheduled to begin in early 2024.

Antibody 130
article thumbnail

Using analytics and bioassays to de-risk your mRNA LNP drug development programme

Pharmaceutical Technology

Some of the variables include the chemical composition of the LNP, the manufacturing process and of course the RNA itself, whose design and production must elicit the intended therapeutic outcome.” They can’t be derived from animal products, but they are often synthesised in low purity – 60%-70% pure. weight abundance.

Bioassay 130
article thumbnail

4th Gene Therapy Analytical Development Summit 2022

pharmaphorum

This year’s summit returns in-person to Boston to reunite 300+ analytical experts in innovative biotech, pharma and academia to continue to develop resilient, long-lasting and robust analytical tools to enhance the safety, quality, and efficacy of gene therapy products.

article thumbnail

At-home Self-testing: A Giant Leap Towards Transformation in Diagnostic Sector

Roots Analysis

In the health industry, digitization has evolved over time with numerous advances to ensure that everyone has equitable access to health products and medical specialists. Cell and Gene Therapy Bioassay Services Market, 2021-2030. You may also be interested in the following titles: Targeted protein degradation market , 2022-2035.

article thumbnail

How ML and automation are changing the future of protein therapeutics

Drug Discovery World

Linking our wet lab efforts with the output of the ML platform (or dry lab) creates a productive cycle of generate, build, measure, and learn to provide the right data at the right scale to unlock value for designing the right medicines quickly, which can then be tested in the clinic and brought to patients rapidly.

Protein 52